Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Hosted content
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Hosted content
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 64, Issue 12
TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
XML
Hepatology
Original article
TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice
Online download statistics by month:
Online download statistics by month: November 2014 to March 2024
Abstract
Full
Pdf
Nov 2014
283
57
67
Dec 2014
316
128
87
Jan 2015
97
108
86
Feb 2015
90
87
56
Mar 2015
186
108
89
Apr 2015
80
58
50
May 2015
56
64
51
Jun 2015
66
61
35
Jul 2015
65
59
47
Aug 2015
69
74
57
Sep 2015
39
59
67
Oct 2015
32
54
33
Nov 2015
879
70
101
Dec 2015
566
79
47
Jan 2016
263
47
52
Feb 2016
166
52
42
Mar 2016
127
24
29
Apr 2016
134
50
47
May 2016
94
48
24
Jun 2016
73
33
35
Jul 2016
71
61
51
Aug 2016
86
51
35
Sep 2016
73
32
28
Oct 2016
53
35
26
Nov 2016
69
50
83
Dec 2016
63
32
22
Jan 2017
63
38
20
Feb 2017
5
27
18
Mar 2017
3
27
14
Apr 2017
2
52
33
May 2017
3
50
20
Jun 2017
14
41
13
Jul 2017
44
41
18
Aug 2017
49
36
7
Sep 2017
65
45
15
Oct 2017
70
56
19
Nov 2017
73
58
42
Dec 2017
52
46
24
Jan 2018
98
88
18
Feb 2018
78
68
27
Mar 2018
68
64
32
Apr 2018
50
46
19
May 2018
100
84
21
Jun 2018
86
74
22
Jul 2018
114
92
4
Aug 2018
79
54
14
Sep 2018
69
43
22
Oct 2018
52
45
22
Nov 2018
75
61
24
Dec 2018
74
68
27
Jan 2019
87
81
43
Feb 2019
97
68
36
Mar 2019
93
69
25
Apr 2019
98
62
36
May 2019
41
35
21
Jun 2019
95
82
20
Jul 2019
74
62
22
Aug 2019
73
65
52
Sep 2019
64
48
32
Oct 2019
56
48
28
Nov 2019
111
57
22
Dec 2019
228
55
11
Jan 2020
72
65
23
Feb 2020
45
37
20
Mar 2020
96
87
30
Apr 2020
71
65
17
May 2020
65
54
16
Jun 2020
54
51
11
Jul 2020
52
46
22
Aug 2020
58
50
10
Sep 2020
65
53
19
Oct 2020
71
44
20
Nov 2020
58
48
12
Dec 2020
70
57
29
Jan 2021
75
66
13
Feb 2021
28
21
13
Mar 2021
67
48
26
Apr 2021
94
88
18
May 2021
70
65
16
Jun 2021
55
55
16
Jul 2021
29
29
17
Aug 2021
32
32
19
Sep 2021
32
31
15
Oct 2021
40
39
22
Nov 2021
37
31
33
Dec 2021
41
42
12
Jan 2022
50
45
17
Feb 2022
44
39
13
Mar 2022
78
65
23
Apr 2022
61
54
18
May 2022
62
55
9
Jun 2022
93
59
17
Jul 2022
59
41
10
Aug 2022
67
49
12
Sep 2022
58
56
8
Oct 2022
56
33
18
Nov 2022
45
38
11
Dec 2022
37
26
3
Jan 2023
37
24
16
Feb 2023
71
55
20
Mar 2023
46
39
23
Apr 2023
57
40
12
May 2023
36
26
14
Jun 2023
27
19
4
Jul 2023
28
18
16
Aug 2023
39
29
20
Sep 2023
52
40
10
Oct 2023
129
104
16
Nov 2023
180
164
14
Dec 2023
67
53
12
Jan 2024
73
77
45
Feb 2024
68
37
16
Mar 2024
57
40
106
Total
9653
6146
3142
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF